RetinalGenix Technologies (RTGN) Depreciation & Amortization (CF) (2022 - 2025)
RetinalGenix Technologies (RTGN) reported Depreciation & Amortization (CF) of $31.0 for Q2 2025, up 24.0% on a YoY basis from $25.0 in Q2 2024, and up 24.0% sequentially from $25.0 in Q1 2025.
RetinalGenix Technologies (RTGN) Depreciation & Amortization (CF) (2022 - 2025) Analysis & Trends
RetinalGenix Technologies (RTGN) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $31.0 in Q2 2025.
- For the quarter ending Q2 2025, Depreciation & Amortization (CF) rose 24.0% year-over-year to $31.0; the trailing twelve-month figure through Mar 2026 stood at $31.0 (down 69.0% YoY), and the FY2025 full-year result was $56.0, down 44.0% from the prior year.
- Depreciation & Amortization (CF) rose to $31.0 in Q2 2025, from $25.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $31.0 in Q2 2025 to a low of $25.0 in Q1 2023.
- A 4-year average of $25.64 and a median of $25.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) dropped 3.85% in 2023 and grew 24.0% in 2025, its largest moves.
- Tracing RTGN's Depreciation & Amortization (CF) over 4 years: stood at $26.0 in 2022, then declined by 3.85% to $25.0 in 2023, then changed by 0.0% to $25.0 in 2024, then gained by 24.0% to $31.0 in 2025.
- Business Quant data shows RTGN's Depreciation & Amortization (CF) at $31.0 in Q2 2025, $25.0 in Q1 2025, and $25.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 31.00 |
| Jun 30, 2025 | 31.00 |
| Mar 31, 2025 | 25.00 |
| Mar 31, 2025 | 25.00 |
| Dec 31, 2024 | 25.00 |
| Dec 31, 2024 | 25.00 |
| Sep 30, 2024 | 25.00 |
| Sep 30, 2024 | 25.00 |
| Jun 30, 2024 | 25.00 |
| Jun 30, 2024 | 25.00 |
| Mar 31, 2024 | 25.00 |
| Mar 31, 2024 | 25.00 |
| Dec 31, 2023 | 25.00 |
| Dec 31, 2023 | 25.00 |
| Sep 30, 2023 | 25.00 |
| Sep 30, 2023 | 25.00 |
| Jun 30, 2023 | 25.00 |
| Jun 30, 2023 | 25.00 |
| Mar 31, 2023 | 25.00 |
| Mar 31, 2023 | 25.00 |